Aug 2026· ACS Chemical Biology· Vol 21, pp. 2369-2383· 0 citations· 54 references
Medicine
TL;DR
These results establish a modular, MG- and phosphorylation-dependent platform for engaging 14-3-3 in a p53 context and for evaluating how chemical stabilization translates from biochemical interaction control to cellular pathway-level readouts.
Abstract
The tumor suppressor p53 is regulated by phosphorylation-dependent protein-protein interactions, including via binding to 14-3-3 adaptor proteins, which can tune p53 activity. Molecular glue (MG)-induced stabilization of 14-3-3/client interactions offers an attractive strategy to probe such networks, but cellular engagement is often constrained by context-dependent phosphorylation and interaction occupancy. Here, we engineered phosphorylation- and MG-dependent 14-3-3 interaction cassettes (IC1 and IC2) and fused them to p53 to promote recruitment of endogenous 14-3-3 proteins in human cells. Biochemical characterization establishes high-affinity binding of the phosphorylated cassettes to 14-3-3 and enhanced in vitro stabilization by the 14-3-3 molecular glue 3'-deacetylated fusicoccin-A (FC-A). In HEK293T cells, Flag-p53-IC1 and Flag-p53-IC2 co-immunoprecipitated native 14-3-3 proteins. Mutation of the cassette's phospho-accepting serine to alanine abolished binding, confirming phosphorylation dependent recruitment. Transcriptomic profiling of transiently transfected cells reveals cassette-dependent remodeling of a p53-associated gene expression landscape. Together, these results establish a modular, MG- and phosphorylation-dependent platform for engaging 14-3-3 in a p53 context and for evaluating how chemical stabilization translates from biochemical interaction control to cellular pathway-level readouts.
14-3-3 Proteins are hub proteins with an extensive interactome of phosphorylated client proteins, making them attractive targets for molecular glues (MGs) that stabilize specific 14-3-3/client protein complexes. However, selectively stabilizing individual 14-3-3 protein-protein interactions (PPIs) remains a key challen...
Marloes A. M. Pennings, G. Lauffer, Markella Konstantinidou et al.· Journal of Medicinal Chemist...· 0 citations
Direct phospho-proteoform delivery is established, which combines genetic code expansion-enabled production of proteins containing the nonhydrolyzable phosphoserine analog nhpS in E. coli with electroporation-based delivery of purified proteins into human cells with control over identity, dose, and timing, independent...
Moriah H. Mathis, Stanislau Stanisheuski, Ryan A. Mehl et al.· Chemical Science· 0 citations
YWHA/14-3-3 proteins are conserved phosphoserine/phosphothreonine-binding adaptors that coordinate signaling-complex assembly, subcellular localization, stress responses and cell-state transitions. Although often discussed as a single adaptor family, colorectal cancer (CRC) studies suggest that individual YWHA isoforms...
Qian Liu, Ru-Dong Li, Wei Ye et al.· Frontiers in Oncology· 0 citations
Summary In αβ T cells, ligand binding to T cell receptor (TCR) triggers conformational changes at CD3ε subunits to expose the proline-rich sequence (PRS), which binds to the non-catalytic region of tyrosine kinase (Nck) via its Src homology 3 (SH3).1 domain. Recruitment of Nck to CD3ε initiates phosphorylation of vario...
Simple Summary Cells experience physical cues from their environment, which influence gene expression through mechanotransduction. We previously found that Ubiquitin-conjugating enzyme E2 A/B (UBE2A/B) move into the nucleus under stiff or low-density conditions, promoting histone H2B (H2B) monoubiquitination and cell g...